Efficacy of Combined Traditional Chinese Medicine and Western Medicine in Treating Benign Prostatic Hyperplasia: A Randomized Controlled Trial

• • Combination therapy (TCM + tamsulosin) achieved a significantly greater IPSS reduction (mean change -8.2 vs -5.4, p<0.01) compared to tamsulosin monotherapy, indicating enhanced symptom relief in BPH patients. • • Peak urinary flow rate (Qmax) improved by +4.5 mL/s in the combination group versus +2.8 mL/s in the control group (p<0.05), demonstrating objective improvement in urinary obstruction. • • Post-void residual volume (PVR) decreased by 32 mL in the combination group versus 18 mL in the control group (p<0.05), suggesting better bladder emptying and reduced risk of urinary retention. • • The combination regimen showed a favorable safety profile with no significant increase in adverse events, supporting its clinical applicability for long-term BPH management.